RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
GC Biopharma Stock

GC Biopharma Equity 2025

GC Biopharma Equity

1.25 T KRW

Ticker

006280.KS

ISIN

KR7006280002

In 2025, GC Biopharma's equity was 1.25 T KRW, a -3.66% increase from the 1.3 T KRW equity in the previous year.

GC Biopharma Aktienanalyse

What does GC Biopharma do?

GC Biopharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing GC Biopharma's Equity

GC Biopharma's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding GC Biopharma's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating GC Biopharma's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

GC Biopharma's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in GC Biopharma’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about GC Biopharma stock

What is the equity of GC Biopharma this year?

GC Biopharma has equity of 1.25 T KRW this year.

What was the equity of GC Biopharma compared to the previous year?

The equity of GC Biopharma has increased/decreased by -3.66% decreased compared to the previous year.

What impact does a high equity have on investors of GC Biopharma?

A high equity is advantageous for investors of GC Biopharma as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of GC Biopharma?

A low equity can be a risk for investors of GC Biopharma, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of GC Biopharma affect the company?

An increase in equity of GC Biopharma can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of GC Biopharma affect the company?

A reduction in equity of GC Biopharma can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of GC Biopharma?

Some factors that can affect the equity of GC Biopharma include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of GC Biopharma so important for investors?

The equity of GC Biopharma is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can GC Biopharma take to change the equity?

To change equity, GC Biopharma can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does GC Biopharma pay?

Over the past 12 months, GC Biopharma paid a dividend of 1,500 KRW . This corresponds to a dividend yield of about 1.13 %. For the coming 12 months, GC Biopharma is expected to pay a dividend of 1,555.91 KRW.

What is the dividend yield of GC Biopharma?

The current dividend yield of GC Biopharma is 1.13 %.

When does GC Biopharma pay dividends?

GC Biopharma pays a quarterly dividend. This is distributed in the months of January, January, January, January.

How secure is the dividend of GC Biopharma?

GC Biopharma paid dividends every year for the past 23 years.

What is the dividend of GC Biopharma?

For the upcoming 12 months, dividends amounting to 1,555.91 KRW are expected. This corresponds to a dividend yield of 1.17 %.

In which sector is GC Biopharma located?

GC Biopharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von GC Biopharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of GC Biopharma from 4/1/2025 amounting to 1,500 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2024.

When did GC Biopharma pay the last dividend?

The last dividend was paid out on 4/1/2025.

What was the dividend of GC Biopharma in the year 2024?

In the year 2024, GC Biopharma distributed 1,500 KRW as dividends.

In which currency does GC Biopharma pay out the dividend?

The dividends of GC Biopharma are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von GC Biopharma

Our stock analysis for GC Biopharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of GC Biopharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.